Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.
about
Opioids and Viral Infections: A Double-Edged SwordInteractions of Opioids and HIV Infection in the Pathogenesis of Chronic PainSynergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytesMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesHIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.Rat nucleus accumbens core astrocytes modulate reward and the motivation to self-administer ethanol after abstinenceHIV transactivator of transcription enhances methamphetamine-induced Parkinson's-like behavior in the rats.Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphineInteractions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.Sensitization of enteric neurons to morphine by HIV-1 Tat protein.Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and deathDiffering roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposureMorphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.Opiate drug use and the pathophysiology of neuroAIDS.Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.Mechanism(s) involved in opioid drug abuse modulation of HANDMorphine exposure during HIV encephalitis in SCID mice.A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types.HIV-1 Tat Inhibits Autotaxin Lysophospholipase D Activity and Modulates Oligodendrocyte DifferentiationInhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors.Ligand-gated purinergic receptors regulate HIV-1 Tat and morphine related neurotoxicity in primary mouse striatal neuron-glia co-cultures.Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability.Neuronal toxicity in HIV CNS diseaseDevelopment of in vivo drug-induced neurotoxicity models.Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine.GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicityImportance of Autophagy in Mediating Human Immunodeficiency Virus (HIV) and Morphine-Induced Metabolic Dysfunction and Inflammation in Human Astrocytes.Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.Microglia and drug-induced plasticity in reward-related neuronal circuits.Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats.Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
P2860
Q26742182-EFC2216A-3A2C-4F69-B390-3C7831F26BEFQ26768068-E4DC2D98-05D6-4284-BF63-EC4359CC6D42Q28484371-5F3714EA-9778-4FCD-B27D-6632001032C7Q28539889-4184E4A8-A917-4C86-B5E9-A6209B0852BEQ33647438-44FD3927-C4A2-4F90-B8DE-AB63657CC9B4Q34197724-C5C659B4-08E6-4F7A-B132-C6C28BDBEE3AQ34356997-E7605A98-2C02-4A6E-A10B-049D1E5EDF35Q34536059-7BA1204B-CC1C-4FCD-9452-7F0E7287343EQ34988973-56E9C3BD-5A0B-4CD8-81F2-0386D4673F08Q35007339-3822D30B-5212-4745-89E9-3FDEBACED3F4Q35216669-FDC2C637-F033-4785-BECE-A156BCF73A67Q35236345-65C617C7-8629-47BA-8C36-FF06EED3E81EQ35763921-6BF62FD4-EF9E-4D95-A869-9C1BBD3EEEDFQ35779848-A626066C-2995-4E30-BA69-5DF0F74659C2Q35818267-1EA2779C-EE59-4669-9981-A11301A5C0C1Q35857045-E303D3A2-A5CB-4C1E-A765-A81680E8EF1AQ35941437-59F44F54-CA5A-438C-B88B-38FB4F358FE4Q36109980-461CB13E-C429-40F5-BEF2-AEE9BA047B26Q36201412-68FDC0CC-C119-4B8E-A3F3-B0964BA7247CQ36432328-9861ACE7-FDB9-4372-8970-C39454B8796DQ36590733-06AB9FF6-FBD7-491A-AE7F-B2BD5659C6B8Q36687603-A7417065-D290-4C27-A6C3-98B16609255BQ36839084-30542597-8C45-4244-8C7B-4AF5D05B7331Q36984167-B43BEF58-36E7-4B72-99B3-64CECABF103DQ37064333-3B00D27C-ACAB-4C29-947A-749BEA7EA968Q37282230-9BA23FEC-D4A7-4C6D-B87F-38C067F3F69AQ37399037-5BAA1670-942A-46AE-9ECF-5BDAB3DB1F52Q37646749-4A8FF039-CC9E-4BDB-8F12-173F375DDB25Q37689277-69FC1163-41BF-4570-BF83-838C471C46C8Q38101560-9A03DE0B-3D97-4866-B7F7-0A2D477DF9ADQ38259808-811F66F7-9C04-4D22-A430-C8D95E9F3D34Q38655315-CAEA7BBF-6015-494B-A55B-4FB5AC782BC1Q38917051-C219B641-B8BE-4209-AB7C-5F59D2F48C7BQ40090533-ABEC3D14-BFE0-4DC8-9B06-FE8904F0372EQ40112882-D7F7AF58-3964-4D6D-A802-6B2856867CF5Q40487821-E8384CF4-283B-4C3B-9DE2-96CBCA5AFDB2Q42069199-D8FF0226-4122-482C-9657-C4B0372F74CEQ42715611-738A751A-8B93-44C0-93E4-B08C2B366E56Q44350542-A8C8FE6D-DE3A-461D-876B-A593B9E6CFBEQ45063674-E8C812AA-2E8D-4EBC-9320-F59C2136517E
P2860
Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Morphine potentiates neurodege ...... ioid receptor-expressing glia.
@ast
Morphine potentiates neurodege ...... ioid receptor-expressing glia.
@en
type
label
Morphine potentiates neurodege ...... ioid receptor-expressing glia.
@ast
Morphine potentiates neurodege ...... ioid receptor-expressing glia.
@en
prefLabel
Morphine potentiates neurodege ...... ioid receptor-expressing glia.
@ast
Morphine potentiates neurodege ...... ioid receptor-expressing glia.
@en
P2093
P2860
P356
P1433
P1476
Morphine potentiates neurodege ...... ioid receptor-expressing glia.
@en
P2093
Kurt F Hauser
Nazira El-Hage
Pamela E Knapp
Sandra P Welch
Shiping Zou
Yun-Kyung Hahn
P2860
P304
P356
10.1093/BRAIN/AWR281
P407
P577
2011-11-18T00:00:00Z